Literature DB >> 24388642

Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.

Blanca I Restrepo1, Larry S Schlesinger2.   

Abstract

Tuberculosis (TB) is known to be fueled by HIV as well as social and economic factors. With progression of the diabetes mellitus (DM) pandemic in countries where TB is also endemic, focus is increasing on the potential links between DM and TB. Despite the magnitude of the DM-TB association worldwide, it is striking how little we know about the underlying biology that promotes this association which is a major concern to public health. In this review we summarize current findings regarding the alterations in the innate and adaptive immune responses of DM patients to Mycobacterium tuberculosis (Mtb). Current findings suggest underperforming innate immunity followed by a hyper-reactive cellular response to Mtb, but the contribution of these altered responses to TB susceptibility or to the more adverse clinical outcomes of TB patients with DM remains unclear. Elucidating the basic mechanisms underlying the higher susceptibility of DM patients to TB should lead to a strategy for stratification of the millions of DM patients worldwide into those with the highest TB risk for targeted TB prevention.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Diabetes; Hyperglycemia; Innate immunity; Review; Tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 24388642      PMCID: PMC4019931          DOI: 10.1016/S1472-9792(13)70004-0

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   2.973


  54 in total

1.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

2.  Matrix-assisted laser desorption/ionization capabilities in the study of non-enzymatic protein glycation.

Authors:  A Lapolla; D Fedele; R Seraglia; S Catinella; P Traldi
Journal:  Rapid Commun Mass Spectrom       Date:  1994-08       Impact factor: 2.419

3.  Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria.

Authors:  Kai Soo Tan; Kok Onn Lee; Kee Chung Low; Akshamal Mihiranga Gamage; Yichun Liu; Gek-Yen Gladys Tan; Hui Qi Vanessa Koh; Sylvie Alonso; Yunn-Hwen Gan
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

Review 4.  Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

Authors:  Jun Panee
Journal:  Cytokine       Date:  2012-07-04       Impact factor: 3.861

5.  [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis].

Authors:  K Tsukaguchi; H Okamura; M Ikuno; A Kobayashi; A Fukuoka; H Takenaka; C Yamamoto; T Tokuyama; Y Okamoto; A Fu; M Yoshikawa; T Yoneda; N Narita
Journal:  Kekkaku       Date:  1997-11

6.  Diabetic control and risk of tuberculosis: a cohort study.

Authors:  Chi C Leung; Tai H Lam; Wai M Chan; Wing W Yew; Kin S Ho; Gabriel M Leung; Wing S Law; Cheuk M Tam; Chi K Chan; Kwok C Chang
Journal:  Am J Epidemiol       Date:  2008-04-08       Impact factor: 4.897

Review 7.  Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.

Authors:  X Palomer; J M González-Clemente; F Blanco-Vaca; D Mauricio
Journal:  Diabetes Obes Metab       Date:  2008-03       Impact factor: 6.577

8.  Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control.

Authors:  Diana I Gomez; Marcel Twahirwa; Larry S Schlesinger; Blanca I Restrepo
Journal:  Tuberculosis (Edinb)       Date:  2012-11-03       Impact factor: 2.973

9.  Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence.

Authors:  Catherine R Stevenson; Nita G Forouhi; Gojka Roglic; Brian G Williams; Jeremy A Lauer; Chirstopher Dye; Nigel Unwin
Journal:  BMC Public Health       Date:  2007-09-06       Impact factor: 3.295

Review 10.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

View more
  40 in total

1.  Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.

Authors:  Nathella P Kumar; Rathinam Sridhar; Dina Nair; Vaithilingam V Banurekha; Thomas B Nutman; Subash Babu
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

2.  Clinical Pharmacokinetics of Rifampin in Patients with Tuberculosis and Type 2 Diabetes Mellitus: Association with Biochemical and Immunological Parameters.

Authors:  S E Medellín-Garibay; N Cortez-Espinosa; R C Milán-Segovia; M Magaña-Aquino; J M Vargas-Morales; R González-Amaro; D P Portales-Pérez; S Romano-Moreno
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

3.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

4.  Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection.

Authors:  Nathella Pavan Kumar; Parakkal Jovvian George; Paul Kumaran; Chandra Kumar Dolla; Thomas B Nutman; Subash Babu
Journal:  J Infect Dis       Date:  2014-06-06       Impact factor: 5.226

5.  Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.

Authors:  Nathella Pavan Kumar; Vaithilingam V Banurekha; Dina Nair; Paul Kumaran; Chandra Kumar Dolla; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2015-08-28       Impact factor: 3.131

6.  Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.

Authors:  R L Hensel; R R Kempker; J Tapia; A Oladele; H M Blumberg; M J Magee
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

Review 7.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.

Authors:  Katharina Ronacher; Reinout van Crevel; Julia A Critchley; Andrew A Bremer; Larry S Schlesinger; Anil Kapur; Randall Basaraba; Hardy Kornfeld; Blanca I Restrepo
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

8.  Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.

Authors:  R C Chukwuanukwu; C C Onyenekwe; L Martinez-Pomares; R Flynn; S Singh; G I Amilo; N R Agbakoba; J O Okoye
Journal:  Clin Exp Immunol       Date:  2016-10-21       Impact factor: 4.330

Review 9.  Impact of diabetes on the natural history of tuberculosis.

Authors:  Blanca I Restrepo; Larry S Schlesinger
Journal:  Diabetes Res Clin Pract       Date:  2014-07-14       Impact factor: 5.602

Review 10.  Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases.

Authors:  Robert N Mahon; Richard Hafner
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.